Cargando…
STAT3, a Master Regulator of Anti-Tumor Immune Response
Immune cells in the tumor microenvironment regulate cancer growth. Thus cancer progression is dependent on the activation or repression of transcription programs involved in the proliferation/activation of lymphoid and myeloid cells. One of the main transcription factors involved in many of these pa...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6770459/ https://www.ncbi.nlm.nih.gov/pubmed/31480382 http://dx.doi.org/10.3390/cancers11091280 |
_version_ | 1783455477964734464 |
---|---|
author | Rébé, Cédric Ghiringhelli, François |
author_facet | Rébé, Cédric Ghiringhelli, François |
author_sort | Rébé, Cédric |
collection | PubMed |
description | Immune cells in the tumor microenvironment regulate cancer growth. Thus cancer progression is dependent on the activation or repression of transcription programs involved in the proliferation/activation of lymphoid and myeloid cells. One of the main transcription factors involved in many of these pathways is the signal transducer and activator of transcription 3 (STAT3). In this review we will focus on the role of STAT3 and its regulation, e.g., by phosphorylation or acetylation in immune cells and how it might impact immune cell function and tumor progression. Moreover, we will review the ability of STAT3 to regulate checkpoint inhibitors. |
format | Online Article Text |
id | pubmed-6770459 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-67704592019-10-30 STAT3, a Master Regulator of Anti-Tumor Immune Response Rébé, Cédric Ghiringhelli, François Cancers (Basel) Review Immune cells in the tumor microenvironment regulate cancer growth. Thus cancer progression is dependent on the activation or repression of transcription programs involved in the proliferation/activation of lymphoid and myeloid cells. One of the main transcription factors involved in many of these pathways is the signal transducer and activator of transcription 3 (STAT3). In this review we will focus on the role of STAT3 and its regulation, e.g., by phosphorylation or acetylation in immune cells and how it might impact immune cell function and tumor progression. Moreover, we will review the ability of STAT3 to regulate checkpoint inhibitors. MDPI 2019-08-30 /pmc/articles/PMC6770459/ /pubmed/31480382 http://dx.doi.org/10.3390/cancers11091280 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Rébé, Cédric Ghiringhelli, François STAT3, a Master Regulator of Anti-Tumor Immune Response |
title | STAT3, a Master Regulator of Anti-Tumor Immune Response |
title_full | STAT3, a Master Regulator of Anti-Tumor Immune Response |
title_fullStr | STAT3, a Master Regulator of Anti-Tumor Immune Response |
title_full_unstemmed | STAT3, a Master Regulator of Anti-Tumor Immune Response |
title_short | STAT3, a Master Regulator of Anti-Tumor Immune Response |
title_sort | stat3, a master regulator of anti-tumor immune response |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6770459/ https://www.ncbi.nlm.nih.gov/pubmed/31480382 http://dx.doi.org/10.3390/cancers11091280 |
work_keys_str_mv | AT rebecedric stat3amasterregulatorofantitumorimmuneresponse AT ghiringhellifrancois stat3amasterregulatorofantitumorimmuneresponse |